|
 |
|
 |
|
MEET THE MARC SCIENTISTS!
Click on each person for a list of video clips of them talking about their research, why they got involved in science, and how their work aims to solve problems with drug abuse.
Aaron Janowsky, MARC Director
Dr. Janowsky's fascination with the brain led him to a career in pharmacology. He now studies the chemical actions of drugs like methamphetamine and also mental disorders such as schizophrenia that involve related brain systems. |
 |
| Tamara Phillips, MARC Scientific Director
One college course in behavioral genetics was all it took to get Dr. Phillips hooked on unraveling the mysteries of how our genes affect behaviors related to drug abuse. |
 |
| William Hoffman , MARC investigator
As a practicing psychiatrist, Dr. Hoffman sees first-hand the impact of drug abuse on patients. His research uses magnetic-resonance imaging (MRI) to study changes in the brains of recovering methamphetamine users. |
 |
| Jennifer Loftis, MARC investigator
With co-investigator Marilyn Huckans, Dr. Loftis studies how the body's immune-system response is involved in the effects of methamphetamine addiction, and how immunotherapies could aid in recovery. |
 |
| Marilyn Huckans, MARC investigator
With co-investigator Jennifer Loftis, Dr. Huckans -- also a clinical psychologist -- is looking at new approaches to addiction treatment based in neuroimmunology. |
 |
| Suzanne Mitchell, MARC investigator
Impulsivity -- taking actions without regard to their potential consequences -- is a trait now linked with many drug-abuse behaviors and the subject of Dr. Mitchell's MARC research. |
 |
| Jacob Raber, MARC investigator
A desire to improve therapies for neurological diseases led Dr. Raber into research. His MARC work has investigated the effects of prenatal methamphetamine exposure on both mice and humans. |
 |
|
| |
 |